Beta‐site APP‐cleaving enzyme 1 (BACE1), a critical rate‐limiting enzyme that synthesizes β‐amyloid peptide (Aβ), is an important marker of early pathological changes in Alzheimer's disease (AD). Here, BACE1 is linked to early-onset autosomal dominant Alzheimer disease.